Estrogen tightly regulates the levels of circulating gonadotropins, but a direct effect of estrogen receptor alpha (ER␣) on the mammalian LH␤ gene has remained poorly defined. We demonstrate here that ER␣ can associate with the LH␤ promoter through interactions with Sf-1 and Pitx1 without requiring an estrogen response element (ERE). We show that gonadotropin-releasing hormone (GnRH) promotes ER␣ ubiquitylation and also degradation while stimulating expression of ubc4. GnRH also increases the association and lengthens the cycling time of ER␣ on the LH␤ promoter. The ER␣ association and transactivation of the LH␤ gene, as well as ER␣ degradation, are increased following ubc4 overexpression, while the effects of GnRH are abated following ubc4 knockdown. Our results indicate that ER␣ ubiquitylation and subsequent transactivation of the LH␤ gene can be induced by increasing the levels of the E2 enzyme as a result of signaling by an extracellular hormone, thus providing a new form of cross talk in hormonally stimulated regulation of gene expression.
Estrogen tightly regulates the levels of circulating gonadotropins, but a direct effect of estrogen receptor alpha (ER␣) on the mammalian LH␤ gene has remained poorly defined. We demonstrate here that ER␣ can associate with the LH␤ promoter through interactions with Sf-1 and Pitx1 without requiring an estrogen response element (ERE). We show that gonadotropin-releasing hormone (GnRH) promotes ER␣ ubiquitylation and also degradation while stimulating expression of ubc4. GnRH also increases the association and lengthens the cycling time of ER␣ on the LH␤ promoter. The ER␣ association and transactivation of the LH␤ gene, as well as ER␣ degradation, are increased following ubc4 overexpression, while the effects of GnRH are abated following ubc4 knockdown. Our results indicate that ER␣ ubiquitylation and subsequent transactivation of the LH␤ gene can be induced by increasing the levels of the E2 enzyme as a result of signaling by an extracellular hormone, thus providing a new form of cross talk in hormonally stimulated regulation of gene expression.
Estrogen is a growth factor that stimulates cell growth and differentiation in diverse tissues. One of its most central roles, however, is regulating the production of gonadotropins in the pituitary gland, which is exerted via negative and positive feedback acting at the brain and pituitary. It is the high level of estradiol (E 2 ) at the end of the follicular phase that works synergistically with the hypothalamic gonadotropin-releasing hormone (GnRH) and leads to the preovulatory luteinizing hormone (LH) surge that initiates ovulation.
The synergistic effects of GnRH and E 2 on LH␤ gene expression have been explained by a number of mechanisms, some of which increase the gonadotropes' sensitivity to GnRH. These include E 2 /estrogen receptor (ER) effects on Egr-1, calcium influx, and mitogen-activated protein kinase (MAPK), which comprises part of the GnRH signaling pathway (4, 6, 8, 45) . Conversely, the effects of ER␣ on estrogen-responsive promoters are enhanced by GnRH, possibly involving MAPK phosphorylation of ER␣, which facilitates protein-protein interactions and transactivation, even in the absence of a ligand (9, 19, 33, 36, 53) .
Despite evidence that E 2 enhances LH␤ gene transcription directly, the molecular mechanisms involved have remained elusive (3, 15, 25) . This contrasts with the wellstudied conserved tripartite element comprising Sf-1, Pitx1, and Egr-1 response elements on the proximal promoter, which likely mediates the GnRH response of all mammalian LH␤ genes (3, 11, 20, 46, 58) . Notably, of these, only the rat LH␤ gene contains a possible estrogen response element (ERE). This element, located 1,159 bp upstream of the transcriptional start site, was shown to bind recombinant ER in gel shift assays (55) but bears little resemblance to the consensus ERE motif and is not found on the homologous genes of other mammals. Thus, any direct actions of the liganded ER on the LH␤ gene promoter, if they occur, are likely to involve other DNA binding factors, as shown, for example, for Sp1 and AP-1 (reviewed in reference 19) . This contrasts with the situation in teleost fish, in which all of the isolated LH␤ gene proximal promoters do contain a nearconsensus ERE, and in chinook salmon this was shown to mediate estrogen/ER␣ responsiveness (27, 31) .
ER␣ transactivation appears to involve ubiquitylation which signals proteasome-mediated degradation. A direct correlation between the rate of ER␣ degradation and its transcriptional activity has been noted (32, 48, 62) , although other studies have suggested that it causes down-regulation, as inhibition of the degradation caused an increase in target gene expression (13) . How these two seemingly opposing observations can be reconciled is not yet clear, although Fan et al. (13) suggest promoter context is likely crucial and may relate to the degree that ER␣ availability is a limiting factor in transcription of a particular gene.
The ER␣ is reportedly ubiquitylated after the first round of transcription, allowing its release from the promoter, which may be essential for subsequent ER␣/E 2 -mediated transcription. In this way, the ER␣ cycles on and off the promoter for as long as stimulation is present (37, 48, 54) . This cycling reportedly also occurs in the absence of a ligand, but the cycling times are much shorter; it was suggested that the cycle time is limited by the formation of an active complex which promotes transcription and thus presumably also ER␣ ubiquitylation (48) .
A prevalent role of ubiquitin in mediating regulation of transcription factor activity is recognized: the ubiquitylation is thought to comprise a mechanism to switch off transcription until it is reinitiated, facilitating precise regulation of activator function (38, 50) . Such a mechanism could regulate transcription factors whose activity is tightly controlled, allowing for a precise switching mechanism and rapid reinitiation of transcription in the case of continuous stimulation (30, 40) . Furthermore, a possible direct association between transactivation and ubiquitylation, in which the activation domains of certain factors overlap with elements that signal destruction, has been noted (49, 50) . However, the exact mechanisms through which ubiquitylation is effected at the promoter have yet to be elucidated, while additional roles for this modification in regulating transactivation, other than through protein degradation, have also been proposed (5, 38) . Evidence for nonproteasomal effects of ubiquitylation in transcription include the finding that the APIS complex of the 19S base interacts with the Gal4 activation domain and appears to be involved in transcriptional activation independently of degradation, perhaps through enhancing initiation and/or elongation (14, 16, 43) .
Our hypothesis for this work was that ER␣ interacts with GnRH-mediated signals at the promoter to activate transcription of the LH␤ gene, and our aim was to elucidate the nature of this interaction and its effects. This led us to discover that GnRH exposure increases levels of ubiquitin-conjugating enzyme 4 (ubc4) and causes ubiquitylation of ER␣ while enhancing its transactivation of the LH␤ gene and being involved in its degradation. We further demonstrate that the ER␣ effect on LH␤ gene expression is direct, showing that ER␣ is associated with the LH␤ gene proximal promoter in its native chromatin setting, and propose the mechanism of its recruitment.
MATERIALS AND METHODS
Western blotting. Cells were lysed in extraction buffer (1ϫ phosphate-buffered saline [PBS], 2% sodium dodecyl sulfate [SDS] ) and stored at Ϫ80°C until required. The proteins (30 g/lane) were resolved by electrophoresis on 12% SDS-polyacrylamide gels at 100 V for 2 h and subsequently transferred to an Immuno-Blot polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA) in transfer buffer (39 mM glycine, 48 mM Tris, 0.037% SDS, and 20% methanol) at 30 V for 4 h at 4°C. The membrane was blocked with 10% nonfat milk in Tris-buffered saline-Tween (TBST) (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 1 h at room temperature (RT), washed with TBST for 30 min at RT, and then incubated for 1 h at RT with antisera to ER␣ or ubc4 (H-184 or MC-20 for ER␣ and SC-15000 for ubc4; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and GAPDH (sc-20357; Santa Cruz Biotechnology) diluted 1:1,000 in TBST plus 1% nonfat milk. After washing for 30 min, the membrane was incubated with goat or bovine horseradish peroxidase-conjugated antisera to rabbit or goat immunoglobulin G (0.4 g/ml; Santa Cruz) for 1 h at RT and rinsed in TBST for 30 min at RT. The immunoreactive protein was detected using the Super Signal Pico West chemiluminescent system (Pierce Chemical Co., Rockford, IL), followed by exposure to Cl-XPosure film (Pierce Chemical Co.) for 1 to 5 min.
Cell culture and transient transfections. Cells were cultured in six-well plates and transiently transfected for chloramphenicol acetyltransferase (CAT) assays as described previously (35) using either FuGENE 6 (Roche Diagnostics, Basel, Switzerland) or GenePORTER 2 (Gene Therapy Systems, San Diego, CA). Alternatively, for luciferase assays, cells were grown in 96-well plates, and vectors for rLH␤-luc (200 ng), the transcription factors (80 ng for Sf-1 and ER␣; 10 ng for Pitx1), and simian virus 40-Renilla (2 ng) were transfected using Gene-PORTER 2 after the total amount of DNA had been equilibrated using pWhitescript. Cells were incubated for 40 to 48 h after transfection before harvest. For cells exposed to GnRH (Buserilin) or E 2 (Sigma, St. Louis, MO), these were added to the medium to a final concentration of 10 nM 24 h before harvest unless otherwise stated. MG132 (Z-Leu-Leu-Leu-al; Sigma) was dissolved in dimethyl FIG. 1. GnRH exposure of gonadotropes causes a reduction in ER␣ protein levels via activation of ubc4. (A) L␤T2 cells were cultured and exposed to GnRH for 0 to 24 h. The cells were lysed, and the cell extract was run on 12% SDS gel before Western analysis using antisera to ER␣ (upper panel) or GAPDH (lower panel) as control for protein loading. (B) L␤T2 cells were cultured, some were exposed for 24 h to 10 nM E 2 or GnRH in the absence or presence of MG132, and levels of ER␣ (upper panel) and GAPDH (lower panel) proteins were assessed as described for panel A. (C) Real-time PCR was carried out on L␤T2 cells following GnRH treatment (10 nM; 0 to 8 h), and mRNA levels of ubc4 and ␤-actin were measured and are expressed as the levels (n-fold) over those in untreated cells. CAT and ␤-galactosidase (␤-Gal) assays were performed as described previously (27) , and normalized activity was calculated as a ratio to the basal levels of activity in cells transfected with the control reporter constructs alone. Firefly luciferase and Renilla levels were measured using the Dual-Glo system (Promega) and the Veritas Microplate luminometer (Turner Biosystems), and reporter gene activity was calculated, after normalization, as activity (n-fold) over that in untreated controls.
Plasmid constructs. The csLH␤-CAT and rLH␤-CAT constructs have been described previously (28, 64) . The rLH␤-luc construct was created by ligating the 5Ј flanking region of the rLH␤ gene from the above construct into the pGL3 plasmid (Promega) containing the firefly luciferase reporter gene. Site-directed deletions were carried out using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) using primers comprising 25 bp of the region flanking the response element on both sides and the complementary sequence. All constructs were verified by sequencing.
The ubc4 expression vector was created by amplifying the coding sequence (accession no. BC003923) from L␤T2 cell cDNA using primers to include BamHI and EcoRI restriction sites (5Ј-GACGGATCCATGGCTCTGAAGAG AATC-3Ј and 5Ј-GCAGAATTCTTACATCGCATACTTCTG-3Ј). The amplified and digested fragment was cloned into pCS2.
The small interfering RNA (siRNA) constructs for ubc4 and the green fluorescent protein (GFP) control were constructed in the pSUPER vector (Oligoengine, Seattle, WA) to include the specific 19-bp target sequence for the siubc4 construct (5Ј-GGCTACAATAATGGGGCCA-3Ј) and the sequence for the siGFP construct (5Ј-GAACGGCATCAAGGTGAAC-3Ј). All constructs were verified by sequencing.
The expression vectors for ER␣, Pitx1, and Sf-1 were gifts from F. Pakdel (Rennes, France), J. Drouin (Montreal, Canada), and K. Parker (Durham, NC), respectively. RNA extraction and cDNA synthesis. RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA), and the total RNA (5 g) was reverse transcribed using Superscript II reverse transcriptase (Invitrogen) and random oligo(dT) primers (5 mM; New England Biolabs, Beverly, MA).
Construction and screening of subtractive hybridization libraries. Subtractive hybridization was carried out using the PCR-Select subtraction kit (BD Biosciences Clontech, Palo Alto, CA) using mRNA from unstimulated L␤T2 cells and those exposed to GnRH for 8 h. The secondary PCR products were cloned into pGEM-T-Easy Vector (Promega, Madison, WI), and the up-regulated sequences were enriched by PCR. The library was plated, and individual colonies were picked for sequencing and identification against GenBank using BLAST (http://www.ncbi.nlm.nih.gov/BLAST).
Real-time PCR. Real-time PCR was carried out using the SYBR green I dye with the ABI Prism 7700 sequence detector (Perkin-Elmer Applied Biosystems). Initially, all PCR products were analyzed on agarose gels to ensure specificity of the amplification. PCRs were performed in a 20-l volume, containing the PCR Master Mix, forward and reverse primers (for ubc4, 0.1 M [each] 5Ј-AATGA CCTGGCTCGAGATC-3Ј and 5Ј-GCAACCTTAGGCGGTTTGA-3Ј; for ␤-actin, 5Ј-GCCATGTACGTAGCCATCCA-3Ј and 5Ј-ACGCTCGGTCAGGATC TTCA-3Ј), and 1 l cDNA template. The samples were heated to 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The templates were serially diluted fivefold in order to ensure that the dynamic ranges of both the target and reference were similar, and the comparative cycle threshold (C T ) method was used to compare mRNA levels in the various samples. All samples were assayed in duplicate.
Stable transfection and enrichment of tagged proteins. The mouse ubiquitin coding sequence was PCR amplified from L␤T2 genomic DNA extracted with DNAzol (Invitrogen) using primers designed to include NotI and PacI restriction sites (5Ј-CCTGAGAGCGGCCGCATGCAGATC-3Ј and 5Ј-CCGATTAATTA ATTAGCCACCCCTC-3Ј). The digested product was cloned into pIVEX2.4b (Novagen). The sequence encoding the His tag and ubiquitin was PCR amplified to include BamHI and XhoI restriction sites (CTTTAAGAAGGATCCGCCA CCATGGCTGG and 5Ј-CTCGCTCGAGATCGACTTGCCATG-3Ј) and subcloned into pCMV (Stratagene).
L␤T2 cells were transfected with the His-tagged ubiquitin expression vector using GenePORTER 2. After 48 h, cells were split into 96-well plates with around 500 cells per well. Stably transfected cells were selected by gentamicin (150 g/ml) for 2 weeks, after which individual clones were transferred to six-well plates. After 1 week, these were selected for verification of expression by Western blotting using antisera to the His tag.
The stably transfected cells were lysed by boiling in PBS buffer with 2% SDS, and lysates were incubated at 100°C for 15 min prior to centrifugation (14,000 rpm, 15 min). The extracted protein (500 g) was loaded onto the His tag binding column (Amersham Biosciences, Piscataway, NJ) preequilibrated with 20 mM imidazole in phosphate-NaCl buffer (20 mM phosphate and 0.5 M NaCl, pH 7.4). After binding for 15 min at RT, the unbound proteins were removed by centrifugation (735 ϫ g for 1 min). The column was washed with 240 mM imidazole in the phosphate-NaCl buffer and incubated for 15 min, after which bound proteins were eluted in 100 l of 480 mM imidazole. Proteins were precipitated with trichloroacetic acid and resuspended in 25 l loading buffer before separation on SDS gels and Western analysis, as described above.
Two-hybrid assays. The reporter gene was the Gal4 response element of pG5CAT (Clontech), which was subcloned into the pGL3 firefly luciferase plasmid. The ER␣ cDNA was cloned into the Gal4 DNA binding domain (DBD)-encoding plasmid (pM), and the ER␣, Sf-1, and Pitx1 cDNAs were cloned into the activation domain-encoding plasmid (pVP16; both from Clontech). Cells were plated at 2 ϫ 10 4 cells/well in 96-well plates before transfection using 2 l GenePORTER 2 per well, 0.15 g of the pM and pVP16 fusion constructs, and 0.1 g of the reporter gene, with 0.01 g of simian virus 40-Renilla luciferase as internal control. As marked, ubc4 expression vector was cotransfected at 0.1 g, and total DNA amounts were equilibrated using pWhitescript. Cells were incubated for 40 h before harvest, with E 2 (Sigma) added to the medium (0.1% volume) for the last 24 h. Luciferase activity was measured and normalized, and reporter gene activity was calculated as activity over basal levels (n-fold) generated from transfection of the unfused pM and pVP16 constructs.
Plasmid immunoprecipitation (PIP). ␣T3-1 cells (60% confluent in 100-mm plates) were transfected with 6 g DNA and incubated for 24 h before crosslinking by formaldehyde (1%) for 10 min at RT on a shaking platform. Crosslinking was arrested by addition of glycine (0.125 M) for 5 min at RT. Cells were washed twice with 3 ml PBS containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml pepstatin A) before harvest. Cells
FIG. 2. GnRH and ubc4 stimulate ER␣ monoubiquitylation.
(A) L␤T2 cells stably transfected with a His-tagged ubiquitin (Ub) were exposed to GnRH for 2 h. After lysis, the unenriched (10 g protein/lane) and His tag-enriched (from 500 g protein) lysates from control and GnRH-treated cells were run simultaneously, and Western analysis was used to detect the ER␣ proteins. (B) The stably transfected L␤T2 cells were exposed to GnRH for 0 to 8 h, and the cell lysate was analyzed by Western analysis as above, before (top panel) or after (bottom panel) enrichment for His-tagged proteins. GAPDH levels in the unenriched cell lysate are also shown (middle panel) as loading control. C, control untransfected L␤T2 cells.
from each plate were divided into four samples, centrifuged (8,000 rpm, 10 min, 4°C), resuspended in 500 l SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, protease inhibitors), and incubated on ice for 10 min. Cell debris was removed (13,000 rpm, 10 min, 4°C) and the supernatant transferred to fresh tubes; a 20-l aliquot was kept for DNA input quantitation. The remainder was diluted with chromatin immunoprecipitation (ChIP) dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl, protease inhibitors) before preclearance with protein A Sepharose (PAS) (40 l of 50% [vol/vol]) for 2 h at 4°C on a rotating platform. The PAS was removed (7,000 rpm, 1 min, 4°C) for incubation of the supernatant with ER␣ antisera (H-184; Santa Cruz) overnight at 4°C on a rotating platform.
Proteins were collected by incubation with 40 l of 50% (vol/vol) PAS (1 h, 4°C on a rotating platform), centrifugation (700 rpm, 1 min, 4°C), and sequential washes (4 min on a rotating platform) with each of the following buffers (1 ml): low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM TrisHCl, pH 8.1, 150 mM NaCl), high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 500 mM NaCl), and LiCl wash buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1). This was followed by two washes with Tris-EDTA. After each wash, the proteins were collected by centrifugation (700 rpm, 1 min at 4°C). The DNA was eluted twice in 250 l elution buffer (1% SDS, 0.1 M NaHCO 3 ) and vortexed for 15 min at RT, and the eluate was collected by centrifugation (700 rpm, 1 min). Reverse cross-linking was carried out on the 500 l combined eluates by incubating at 65°C for 4 h with addition of 5 M NaCl (40 l) and RNase (2 l of 100 ng/l). Further incubation was carried out for 1 h at 45°C in the presence of 10 l of 0.5 M EDTA, 20 l of 1 M Tris-HCl, pH 6.5, and 2 l of 10-mg/ml proteinase K. The precipitated DNA was recovered by phenol-chloroform and extracted with isopropanol-sodium acetate. Reverse cross-linking and extraction were carried out similarly for the input DNA.
Precipitated and input DNA served as template for the PCRs using primers to The rLH␤ promoter-CAT6, (B) the csLH␤ 289-bp proximal promoter-CAT3, (C) the longer 3.3-kbp csLH␤ promoter-CAT3 with or without deletion of the ERE (at Ϫ260 bp), or (D) the rLH␤ promoter-luciferase constructs were transfected into COS 1 cells alone or with ER␣, Sf-1, and/or Pitx1 expression vectors. For panels A and B, as indicated, cells were exposed to 10 nM E 2 at the time of transfection; for panels C and D, all cells transfected with ER␣ were exposed to E 2 . Cells were harvested, reporter gene levels were assayed, and normalized values are expressed as the levels (n-fold) over those in control cells. (A to C) Statistical analysis (ANOVA followed by Bonferroni t test) compared mean values separately for groups with and without E 2 (for panels A and B) or for intact and ERE-deleted promoter constructs (for panel C), and similar values (P Ͼ 0.05) are designated with the same letter in uppercase (for control and intact constructs) or lowercase (for E 2 -treated or ERE deletion constructs). (D) Welch's t test was used to compare means of treatments with and without cotransfection of ER␣ plus E 2 . *, P Ͻ 0.05; **, P Ͻ 0.005. Means Ϯ standard errors of the mean (SEM) are shown (n ϭ 4 to 6).
VOL. 25, 2005 GnRH ACTIVATES ER␣ UBIQUITYLATION VIA ubc4 7389 the CAT3 (AAGTTGGGTAACGCCAGGGT and ACAAGGGTGAACACTA TCCC) or CAT6 (GCGACACGGAAATGTTGAAT and ACAAGGGTGAAC ACTATCCC) vector or the csLH␤ (TGTGTACAGCAGGGATCTAA and TT CAGGGTTGGATGCTCTGC) or rat LH␤ (ACGCAAACTCCAACATTAGA and TCCCTACCTTGGGCACTTGG) proximal promoter. Amplified products were separated on ethidium bromide-stained agarose gels. ChIP. L␤T2 cells (80% confluent in 60-mm plates; approximately 5 ϫ 10 6 cells) were treated with E 2 (10 nM) for 1.5 h before addition of GnRH (100 nM). Cross-linking was carried out and arrested, and cells were rinsed and collected as for PIP but in batches of 4 ϫ 10 6 cells. Cells were centrifuged (8,000 rpm, 10 min, 4°C), resuspended, and incubated on ice for 10 min in 800 l SDS lysis buffer. Samples were sonicated with a MISONIX XL2020 sonifier as follows: setting 2, 10 s at 30% duty cycle; setting 1, 10 s at 30% duty cycle with a 30-s interval on ice. Cell debris was removed (13,000 rpm, 10 min, 4°C) and the supernatant transferred to fresh tubes. A 20-l aliquot was removed, and the remainder was diluted and processed as described above. Regions of the proximal promoters of LH␤ or ␤-actin genes were amplified from input and precipitated samples as in the PIP, using primers as described above or the following primers for ␤-actin: 5Ј-GCCATGTACGTAGCCATCCA-3Ј and 5Ј-ACGCTCGGTCAGGATCTTC A-3Ј. Alternatively, quantification was carried out using real-time PCR with primers on the mouse LH␤ proximal promoter (5Ј-GTGAAGCCCACCCACC ACGC-3Ј and 5Ј-CCTTGGGCACCTGGCTTTAT-3Ј) using ABI Prism 7700 and SYBR green. Each sample was assayed in duplicate, and the amount of precipitated DNA, based on average C T , was calculated in relation to that in the input sample.
Statistical analysis. One-way analysis of variance (ANOVA) followed by Bonferroni's or Welch's t test were employed to determine means that were statistically different. Differences were considered significant when P was Ͻ0.05. All experiments were repeated at least three times, and representative individual experiments or compiled results are presented.
RESULTS
GnRH leads to ER␣ ubiquitylation and proteasome-dependent degradation in gonadotropes, which is mediated by stimulation of ubiquitin-conjugating enzyme 4. L␤T2 gonadotrope cells were exposed to GnRH for 0 to 24 h, after which cells were harvested and lysed and Western analysis was carried out to detect changes in ER␣ protein levels. The ER␣ protein level was slightly reduced after 2 h of GnRH exposure, barely detectable after 8 h, and undetectable after 24 h; a similar decrease in the levels of the GAPDH internal control did not occur (Fig. 1A) .
In order to test the role of the proteasome in the inhibitory effect of GnRH on ER␣ protein levels, L␤T2 cells were exposed to GnRH or E 2 for 24 h in the presence or absence of the proteasome inhibitor MG132. The GnRH and E 2 treatments both reduced the level of the ER␣, but in both cases addition of MG132 abated this effect (Fig. 1B) .
In order to detect global transcriptional activation in gonadotropes resulting from GnRH exposure, subtractive hybrid- The intact rLH␤-CAT construct or that lacking the ERE and/or proximal, distal, or both Sf-1 REs was transfected into ␣T3-1 cells; also transfected was the empty CAT6 vector. After 24 h, cells were fixed by formaldehyde before lysis and precipitation of plasmids and associated proteins using antisera to ER␣ or to Sf-1. The cross-linking was reversed and PCR amplification carried out using primers targeting the respective vectors. The top row in each pair (input) shows amplification of the target sequences in the same input samples, and the lower row in each pair (PIP) shows those after precipitation. All treatments were carried out in duplicate, with and without the antisera. (C) Similarly, the intact rLH␤-CAT construct and that lacking the Pitx1 RE were transfected into ␣T3-1 cells, and PIP was carried out in duplicate using antisera to ER␣. Amplification from the input sample is shown, as are those resulting from precipitation with and without antisera. Also shown are nontransfected controls (right column).
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on January 6, 2018 by guest http://mcb.asm.org/ ization was carried out in control and GnRH-treated L␤T2 cells. One of the clones in the subtracted library contained the coding sequence of ubiquitin-conjugating enzyme 4 (ubc4). The effect of GnRH on the mRNA levels of this gene were confirmed in real-time PCR, which showed a continuing increase in transcript levels between 1 and 8 h of exposure to GnRH, reaching nearly ninefold that in the control cells by 8 h, while levels of ␤-actin remained unchanged (Fig. 1C) . Western analysis of L␤T2 cells confirmed that ubc4 protein levels are higher in L␤T2 cells following GnRH treatment and that they could be substantially reduced by transfection of a construct (siubc4) designed to inhibit ubc4 expression ( Fig. 1D and E) . Fig. 1E ). Transfection of the siGFP pSUPER plasmid as a negative control did not alter ER␣ protein levels (normalized value, 0.99 Ϯ 0.03-fold of untreated controls) (not shown). These results indicate that the effect of GnRH in reducing ER␣ protein levels could involve its increase in ubc4, which targets ubiquitylation of ER␣. In order to examine the ubiquitylation status of ER␣ following GnRH exposure, a stably transfected L␤T2 cell line expressing His-tagged ubiquitin was produced. Some of these cells were exposed to GnRH, and the sample was enriched for His-tagged proteins for subsequent Western analysis using ER␣ antisera; unenriched cell extract was run alongside for comparison. The immunoreactive ER␣ in the enriched samples differed from that of the unenriched samples by an additional ca. 10 kDa and was evidently more abundant in GnRHtreated cells, apparently as a result of its increased monoubiquitylation ( Fig. 2A) . A time course study revealed a maximal effect of GnRH on the ubiquitylated ER␣ after 2 h, while it was virtually undetectable after 8 h of exposure. This corresponded with the levels of unubiquitylated ER␣, which dropped dramatically between 2 and 4 h of GnRH exposure, as seen in the unenriched cell lysate (Fig. 2B) .
The liganded ER␣ transactivates LH␤ directly in synergy with Sf-1 and Pitx1 without requiring a consensus ERE. In order to understand how GnRH-mediated ubiquitylation of ER␣ affects its transactivation in the gonadotrope, we first sought to elucidate the effects of ER␣ on the LH␤ gene promoter, both directly and through synergistic interaction with other transcription factors known to mediate GnRH effects on this gene in the gonadotrope (11, 34, 45) . Promoter regions from the LH␤ of rat (rLH␤) and Chinook salmon (csLH␤; the proximal 289 bp), ligated to CAT reporter genes, were transfected into COS 1 cells to test their responsiveness to ER␣ and E 2 . Only the csLH␤ gene promoter responded to ER␣ and E 2 alone, but the activity of both promoters increased dramatically when ER␣ was transfected together with Sf-1 and Pitx1 expression vectors, reaching levels 40-to 60-fold those in unstimulated cells. This effect was dependent on the presence of E 2 ( Fig. 3A and B) . The levels of reporter gene activity in cells transfected with the promoterless CAT vector were unaltered by ER␣ overexpression (not shown). The near-consensus ERE on the csLH␤ proximal promoter was subsequently removed, and the synergistic effect was still apparent; an inhibitory role for this sequence in basal transcription in these cells was also revealed (Fig. 3C) . (B and C) PIP assays were carried out using the intact csLH␤-CAT construct or (B) that lacking the ERE or the Sf-1 RE; also transfected was the empty CAT3 vector; (C) alternatively, intact and Pitx1 RE-deleted csLH␤-CAT constructs were used. Precipitation and other experimental details and presentation of the data are as in Fig. 4 .
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on January 6, 2018 by guest http://mcb.asm.org/ Further experiments were carried out to clarify the relative importance of Sf-1 and Pitx1 for the synergy with ER␣ and E 2 on the rLH promoter using the rLH-luc construct. The levels of reporter gene activity in cells transfected with the promoterless pGL3 vector are increased somewhat by ER␣ and E 2 or by Pitx1 overexpression; these levels of increase were thus subtracted from values obtained with the rLH-luc construct. Although ER␣ overexpression alone failed to increase basal rLH␤ promoter activity, it increased the effects of Sf-1 or Pitx1 by six-or twofold, respectively, while increasing the combined effects of Sf-1 and Pitx1 by as much as sevenfold (Fig. 3D) . Similar experiments on the csLH␤ promoter construct have been carried out previously, revealing the synergistic action of ER␣ with Sf-1 alone, which is increased further with the addition of Pitx1, while ER␣ does not act synergistically with Pitx1 alone (27, 35) .
The mechanism of association of endogenous ER␣ with these LH␤ proximal promoters in the gonadotropes was demonstrated using PIP. For this, the same LH␤-CAT constructs were transfected into mouse gonadotrope ␣T3-1 cells for subsequent cross-linking and pull-down of the ER␣ and associated plasmid DNA. In cells transfected with the rLH␤-CAT construct, but not when the empty CAT vector was used, PCR successfully amplified regions of the construct precipitated using ER␣ antisera. Deletion of the distal nonconsensus ERE (at bp Ϫ1159) (Fig. 4A) revealed that this element is not required for association of ER␣ with the rLH␤ gene promoter, and deletion of the distal Sf-1 binding site (at bp Ϫ119) alone or together with the ERE also failed to abolish ER␣ binding to the rLH␤ gene promoter. However, removal of both proximal (at bp Ϫ51) and distal Sf-1 binding sites abolished ER␣ association with the promoter; this was in accordance with the binding of Sf-1, which was prevented only by the removal of both Sf-1 binding sites (Fig. 4B) . Subsequently, a similar experiment to assess the role of the Pitx1 response element (RE) in association of the ER␣ with the rLH␤ gene promoter was carried out. Removal of this element revealed that the ER␣ association is considerably reduced compared to the intact control promoter construct but is not abolished (Fig. 4C) .
Similar experiments on the csLH␤ gene promoter revealed that the near-consensus ERE (at bp Ϫ260) (Fig. 5A ) is dispensable for ER␣ association with the promoter, but removal of the single Sf-1 binding site at bp Ϫ154 abolished both ER␣ and Sf-1 binding (Fig. 5B) . Removal of the Pitx1 RE did not appear to alter association of the ER␣ with the csLH␤ promoter construct (Fig. 5C) .
Subsequently, reporter gene experiments were carried out in L␤T2 gonadotropes to verify the functionality of these REs in the response of the csLH␤ promoter to ER␣ overexpression. The csLH␤ gene promoter shows a clear response to ER␣ overexpression, and the CAT activity was dramatically reduced with removal of the ERE or Sf-1 REs, while deletion of Pitx1 RE had no effect. In contrast with the PIP studies, however, some induction of promoter activity in response to ER␣ was evident in the absence of the Sf-1 RE, presumably resulting from the high levels of ER␣, which was overexpressed in this study, so facilitating its binding directly to the ERE; this was abolished when both REs were removed (Fig. 6A) . Notably, the effect of ERE deletion to reduce slightly the basal promoter activity differed from that seen in the COS 1 cells, where the deletion gave rise to higher levels of promoter activity (e.g., Fig. 3C ), presumably because it binds an inhibitory factor in COS 1 cells. In contrast to the csLH␤ gene promoter activity, the rLH␤ gene promoter is not responsive to ER␣ expression alone but is responsive only when Sf-1 and Pitx1 are also overexpressed; this additive effect of ER␣ on stimulation by Sf-1 and Pitx1 requires both the Sf-1 and Pitx1 REs (Fig. 6B) .
GnRH-induced ubc4 enhances ER␣ transactivation of the LH␤ gene. In order to verify the role of ubc4 in mediating the GnRH and ER␣ effects on LH␤ gene transcription, L␤T2 cells were transfected with the csLH␤-CAT construct and exposed to GnRH, and some were cotransfected with ER␣ and exposed to E 2 . Some of these cells also had the siubc4 construct cotransfected. GnRH or ER␣ (with E 2 ) alone increased promoter activity by around 7-or 12-fold over controls, while a combination of both treatments increased activity to nearly 35-fold that in control cells. Cotransfection of siubc4 led to a (Fig. 7A) ; transfection of the siGFP pSUPER plasmid as a negative control did not alter transactivation of the LH␤ gene by ER␣, with or without GnRH (P Ͼ 0.1) (not shown). Conversely, the effect of ER␣ overexpression was enhanced by cotransfection with the ubc4 expression vector in both gonadotrope and nongonadotrope cells (Fig. 7B and C) . In the latter, ubc4 overexpression also increased the already synergistic effect of ER␣ with Sf-1 and Pitx1 (Fig. 7C) . In order to test for an effect of ubc4 on ER␣ protein-protein interactions, two-hybrid assays were performed in L␤T2 cells using a Gal4-responsive luciferase reporter gene and ER␣ fused to the Gal4 DBD. These constructs were transfected together with ER␣, Sf-1, or Pitx1 fused to the VP16 activation domain (AD). Some of the cells were also cotransfected with the ubc4 expression vector. Background levels of reporter gene activation by Sf-1, Pitx1, or ER␣ fused to the VP16 AD or ER␣ fused to the Gal4 DBD, where present, were subtracted from the values of the interacting protein; any activity by these constructs alone was unaffected by ubc4 overexpression (not shown). Luciferase activity was elevated in cells transfected with ER␣-Gal4 DBD and Sf-1-VP16 AD, Pitx1-VP16 AD, or ER␣-VP16 AD, and the activity was further increased for all of these pairs following ubc4 overexpression (Fig. 7D) . Similar studies were carried out to test the effect of GnRH exposure on these interactions, which increased generally to a lesser extent than seen following ubc4 overexpression, although the interaction of ER␣ with Pitx1 reached over threefold that in the absence of GnRH (not shown).
GnRH and ubc4 increase the association of ER␣ with the LH␤ gene promoter and lengthen its cycling time. Finally, in FIG. 7 . ubc4 is involved in mediating the effect of GnRH on the LH␤ gene and increases ER␣ transactivation and apparent dimerization and interaction with Sf-1 and Pitx1. (A and B) L␤T2 or (C) COS 1 cells were transfected with the csLH␤ promoter-CAT construct with or without ER␣, Pitx1, and Sf-1 expression vectors and/or exposed to GnRH, as marked. All cells cotransfected with ER␣ were also exposed to E 2 . Some of the cells were also transfected with the siubc4 construct or ubc4 expression vector. After 48 h, cells were harvested and CAT/␤-Gal levels were assayed; results are presented as in Fig. 3 . (D) Two-hybrid assays were carried out in L␤T2 cells using a Gal4 DBD-ER␣ fusion construct with VP16 AD fused to ER␣, Pitx1, or Sf-1, the Gal4-responsive reporter gene, and a Renilla luciferase construct for internal control; all cells were exposed to E 2 (10 nM) at the time of transfection. Luciferase activity was measured 40 h after transfection and is calculated, after normalization and subtraction of any activity of the fusion constructs alone, as the level (n-fold) over the levels in the negative control, in which unfused Gal4 DBD and VP16 AD constructs were transfected (basal level). (A to D) Statistical analysis (ANOVA followed by t test) compared pairs of means for each treatment group, with and without cotransfection of siubc4 or ubc4 expression vector; statistically different means are designated with the following symbols: *, P Ͻ 0.05; **, P Ͻ 0.01; or ***, P Ͻ 0.001. Other values are not significant (N.S.). Means Ϯ SEM are shown (n ϭ 3 to 7). VOL. 25, 2005 GnRH ACTIVATES ER␣ UBIQUITYLATION VIA ubc4 7393
on January 6, 2018 by guest http://mcb.asm.org/ order to reveal the effects of GnRH and ubc4 on the association of the endogenous ER␣ with the native mouse LH␤ promoter, ChIP assays were carried out in mouse L␤T2 gonadotropes. Initially, this was to evaluate changes in the association of endogenous ER␣ with the LH␤ promoter following treatment with GnRH or ubc4 overexpression or knockdown of ubc4 through transfection of the siubc4 construct; all cells except the controls were exposed to E 2 . The association of ER␣ with the LH␤ promoter was evident in all cells exposed to E 2 except those in which the siubc4 construct was transfected. Notably, the siRNA knockdown of ubc4 abolished the clear stimulatory effect of GnRH on ER␣ association with the LH␤ gene promoter (Fig. 8) . Subsequently, effects of these treatments on the cycling of ER␣ on this promoter were tested using L␤T2 cells treated with E 2 at 10-min intervals and then analyzed by ChIP and quantitative real-time PCR. In cells treated with E 2 alone, the ER␣ cycled on and off the proximal promoter at an interval of 30 to 40 min; however, this cycling was abolished in cells which had been transfected with the siubc4 construct (Fig. 9A) . In cells exposed to GnRH, the cycling time increased to around 70 min, while the ER␣ pull-down increased the presence of the LH␤ gene by as much as 1,000-fold over that in the input aliquot; both of these effects were consistently seen in repeated experiments, although the magnitude of increased ER␣ association following GnRH treatment was not always this large. Both of these GnRH effects were absent in siubc4-transfected cells (Fig. 9B) .
Overexpression of ubc4 had an effect that was similar to though less potent than that of GnRH, increasing the apparent affinity of ER␣ for the promoter by as much as 50-fold and increasing the amplitude of the cycles while lengthening the cycle to 50 to 60 min (Fig. 9C) .
DISCUSSION
We report here a novel form of cross talk between two hormonally induced signaling pathways that regulate LH␤ gene transcription, in which GnRH activates ER␣ ubiquitylation, apparently through stimulation of ubc4. We further demonstrate that the stimulatory effect of ER␣ on this gene is mediated through interactions with other regulatory transcription factors on the proximal promoter without necessarily requiring an ERE. The GnRH-stimulated ubc4 increases ER␣ binding to the LH␤ promoter but ultimately also leads to its degradation (Fig. 10) . Estrogen has a crucial role in the estrous cycle, regulating precisely the levels of circulating LH, whose surge is crucial in instigating ovulation. The concept that the liganded ER␣ acts as a molecular switch whose activity can be modified locally at the gonadotrope by GnRH-mediated ubiquitylation is in keeping with this regulatory role while adding a novel dimension to the molecular mechanisms regulating gonadotropin synthesis.
The finding that GnRH up-regulates transcript levels of ubc4 is, to our knowledge, the first report of an E2 enzyme in the ubiquitin pathway being directly stimulated by a cell membrane-bound hormone. GnRH was, however, previously implicated in stimulating ubiquitylation of inositol trisphosphate receptors in the ␣T3-1 gonadotropes, which was dependent on intraluminal Ca 2ϩ , although the molecular mechanisms involved were not described (63) . A recent report indicated that ER␣ is degraded in MCF-7 cells through activation of protein kinase C and not MAPK (34) , both of which are activated in the GnRH signal transduction pathway to the LH␤ gene (39) . Elucidation of the GnRH-stimulated signaling pathways leading specifically to ubc4 transcription in the gonadotropes will require further experimental work.
Results from the present study suggest that ubc4 is the limiting factor for ER␣ ubiquitylation and degradation in the gonadotrope. This was also the case for ubc4-but not ubc2-mediated ubiquitylation of various rat proteins in which immunodepletion decreased and ubc4 administration increased levels of the ubiquitylated proteins (47) . Although some E2 enzymes, including ubc4, are able to ubiquitylate the substrate directly, the E3 enzymes are thought to provide a crucial role in substrate recognition (5, 61) . ER␣ is known to interact with E6AP, which accepts ubiquitin from ubc4 and was associated with ER␣ in re-ChIP experiments (1, 48) . Moreover, gene knockout of E6AP resulted in reproduction-deficient animals with small gonads. However, the females did cycle and even produced litters (56) . Given that estrogen-mediated regulation of cyclical circulating LH levels is crucial to ovulation, it is unlikely that E6AP has a role in regulating LH␤ production. ER␣ has been found to associate with a variety of additional E3 ligases: at the pS2 promoter, ER␣ associates with MDM2 and Rpt6, while other studies have shown ubiquitylation and degradation of ER␣ are mediated through the NEDD8 pathway (12) . NEDD8 enhances ubiquitylation by the SCF (Skp1, Cul-1, ROC1, and F-box protein) E3 complex and increases recruitment specifically of ubc4, so increasing polyubiquitylation (24, 57) .
We have demonstrated the adverse effect of GnRH and ubc4 on ER␣ protein levels, which appear to be concomitant with the increase in affinity of ER␣ to the LH␤ gene promoter. FIG. 8 . GnRH treatment increases the association of ER␣ with the murine LH␤ promoter through ubc4. L␤T2 cells in 60-mm plates were transfected with ubc4 expression vector, siubc4 construct, or neither, as marked, all in duplicate. After 48 h, all cells except controls were treated with E 2 for 90 min before addition of GnRH (100 nM) to some of the cells, as marked. After a further 50 min, ChIP was carried out and PCR used to amplify endogenous mouse LH␤ gene promoter precipitated by the ER␣ antisera and also in an aliquot from the same batch of cells which was designated as the input sample. Amplification of ␤-actin was also performed as a negative control.
The idea that ubc4 ubiquitylates ER␣ and that this regulates its transactivation of the LH␤ gene concurs with a recent report that ubc4 (UbcH5) is required for ligand-mediated ER␣ transactivation of the pS2 promoter (44) . That report further suggested that TBL1 and TBLR1 are the specific adaptor proteins responsible for ubc4 recruitment, which was essential for transactivation by all nuclear receptors tested, although additional more specific E2 enzymes were also recruited: ER␣ requires specifically UbcH7, which may be recruited through interactions with SRC-1 (44, 60) . An earlier study demonstrated that the incubation of ER␣ with an E1 enzyme together with both ubc4 and UbcH7 led to degradation of ER␣ but not of progesterone or thyroid hormone receptors (41) . Our Western analysis revealed only monoubiquitylated ER␣, suggesting that this might be a step distinct from subsequent polyubiquitylation and proteasomal degradation; if this were not the case, we would expect to see at least diubiquitylated ER␣ before further chain elongation and recognition by the proteasome. We thus propose that the actions of GnRH-induced ubc4 comprise a prerequisite to subsequent degradation by additional receptorspecific E2 enzymes, possibly reflecting differentially regulated mono-and polyubiquitylation. The molecular mechanisms involved in differentiating between mono-and polyubiquitylation have yet to be defined, and although a recent report suggested the concentration of the E3 ligase could be the determinant (29) , the latter may well also require additional enzymes, such as E4 ligases involved in promoting chain assembly, or the inhibition of negative regulators (26, 42) (Fig. 10) .
Importantly, in this study we have demonstrated clearly that ER␣ is associated with the LH␤ gene proximal promoter in murine gonadotropes and, in the presence of ligand, can directly stimulate its transcription. We have shown that the recruitment of ER␣ to the LH␤ gene promoter requires the Sf-1 RE, while we also demonstrated direct physical interaction between ER␣ and Sf-1 or Pitx1. Our PIP studies show that the ERE is not required for ER␣ binding to either promoter, while our transfection studies also show ER␣ transactivation in the ERE-deleted constructs; from here we conclude that the ERE is not required for ER␣ transactivation of the LH␤ genes. For the rLH␤ gene promoter, the Pitx1 RE is also crucial for ER␣ transactivation and may play a role in ER␣ recruitment. The csLH␤ operates slightly differently due to the presence of a near-consensus ERE which can bind liganded ER␣ but is dispensable when Sf-1 and Pitx1 are overexpressed, while Pitx1 is not crucial to either recruitment of ER␣ or its transactivation. Our findings are consistent with previous studies on the mammalian LH␤ gene promoter showing that Pitx1's ability to interact synergistically with Sf-1 is largely independent from the requirement for a functional Pitx1 RE (58) . The fact that the rLH␤ gene promoter is unresponsive to the liganded ER␣ unless Sf-1 and Pitx1 are overexpressed indicates a cooperative mechanism of ER␣ recruitment for activation of mammalian LH␤ genes requiring activation of these other transcription factors. This scenario presents the LH␤ genes as those that are not predominantly ERE driven, as described by Fan et al. (13) , and by their argument, LH␤ gene activity would less likely be regulated by ER␣ availability, so that ubiquitylation and proteasomal degradation would not result in desensitization. This supports our results which show that the activation of ubc4 by GnRH appears to cause sensitization to ER␣ transactivation, although we have not demonstrated conclusively that this is due to the ER␣ ubiquitylation and not via an indirect mechanism involving additional transcription factors or other signaling molecules.
Enhanced protein-protein interactions have been attributed to monoubiquitylation (21, 38) . Although we show both ER␣ dimerization and its interactions with Pitx1 and Sf-1 appear to increase when ubc4 is overexpressed, these proteins do not contain any of the domains known to bind ubiquitin (10, 52, 61) . It is possible, therefore, that the increased transactivation of the reporter gene occurs as a result of increased ER␣ interaction with a common coactivator complex, which is independent from but still requires the VP16 AD for transcription initiation in this system. This is feasible, given that a number of coactivators have been shown to contain ubiquitin recognition domains, while the TBLR1-ubc4 complex was proposed to serve specifically to facilitate removal of corepressors and help recruit both the ubiquitin/19S proteasome and the coactivator complex (2, 17, 44). UbcH7 was recently also reported to FIG. 9 . GnRH treatment lengthens the cycling times of ER␣ on the murine LH␤ promoter through ubc4. L␤T2 cells were transfected with (A and B) the siubc4 construct, (C) ubc4 expression vector, or neither for 48 h, after which all cells were treated with E 2 for 90 min. Some of the cells were then exposed to GnRH (100 nM) for 50 min, after which ChIP was carried out, and real-time PCR measured the association of ER␣ with the endogenous murine LH␤ gene promoter. Levels of LH␤ gene promoter precipitated by the ER␣ antisera were calculated in relation to the levels in the aliquot from the same batch of cells, which was designated as the input sample. function as a steroid hormone coactivator, acting through SRC-1 (60) . Further studies will be required to understand whether this increased interaction is a direct consequence of the ER␣ ubiquitylation or a result of the recruitment of additional bridging molecules to facilitate the increased association with the LH␤ gene promoter.
Interestingly, in the gonadotropes, a recent study showed that the ring finger E3, SNURF, coprecipitates with Sf-1 and specifically enhances LH␤ gene transcription (7) . The proposed mechanism for this enhancement was through repressing suppression by androgen receptor which inhibits transcription of this gene through interactions with Sf-1 (23). However, SNURF, which also serves as a coactivator for ER␣, accepts ubiquitin from ubc4 and is up-regulated by estrogen exposure (18, 22, 51) . It is plausible, therefore, that the effects of SNURF on LH␤ gene transcription are in fact through ER␣ ubiquitylation whose increased association with the preinitiation complex, and specifically Pitx1, facilitates competition of the latter with androgen receptor for binding to the putative ligand binding domain of Sf-1 (see reference 59).
Given the fact that GnRH activates a number of factors which bind the proximal LH␤ promoter, we initially hypothesized that GnRH exposure would facilitate formation of this complex and thus would shorten the cycling time of ER␣ on and off the LH␤ gene promoter. Our results show that this is not the case and that ER␣ is, in fact, associated with the promoter for longer cycles following GnRH treatment. This is concomitant with an increase in transactivation of the LH␤ gene, possibly suggesting a change in rate of the stochastic reactions involved in the recruitment of regulatory factors to the promoter. The GnRH exposure also increases the amount of LH␤ gene promoter associated with ER␣, indicating an increase in its affinity, presumably as a result of stronger interaction with the gene-specific and preinitiation transcriptional complexes. This is at least partly due to ubiquitylation, as ubc4 overexpression increases ER␣ association with the promoter and increases synergistic actions of the three transcription factors on LH␤ promoter activity. Conversely, blocking ubc4 expression reduces the ability of ER␣ to associate with the promoter and also virtually abolishes the GnRH effect on promoter activity, indicating not only that ubc4 is required for ER␣ activity but also that ER␣ is crucial in mediating the GnRH effect on the LH␤ gene.
Our results thus present a scenario in which the level of ER␣ ubiquitylation is directly regulated by the signaling pathway of a cell membrane-bound hormone and so increases transactivation of the target gene. This provides a new form of cross talk in hormonally stimulated regulation of gene expression which may be widespread while also revealing novel aspects to the molecular mechanisms regulating gonadotropin synthesis.
